Candel Therapeutics https://validator.w3.org/feed/docs/rss2.html Maha Radhakrishnan, M.D. Patients (clone) ​Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise Dr. Bali Pulendran, PhD. Patients Pipeline Platforms About Media Carl H. June, M.D. Charles Schoch Contact Paul Peter Tak, M.D., Ph.D., FMedSci Gary Nabel, M.D., Ph.D. Register Candel Therapeutics to Present at Upcoming Jefferies Virtual Healthcare Conference Candel Therapeutics Names Carrie S. Cox as Chairman of its Board of Directors Candel Therapeutics Completes Enrollment in Phase 1 Clinical Trial of CAN-2409 in Combination with Opdivo® (nivolumab) for the Treatment of High-Grade Gliomas Candel Therapeutics’ CAN-3110 Clinical Data Selected for Oral Presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Padmanee Sharma, M.D., Ph.D. Investigator Login W. Garrett Nichols, M.D., M.S. Ileen Winick Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments Candel Therapeutics Appoints Diem Nguyen, Ph.D., M.B.A., to its Board of Directors Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting Candel Therapeutics Announces Data from Phase 1 Trial of CAN-3110 in Recurrent High-Grade Glioma at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D. Renee Gaeta Nicoletta Loggia, Ph.D., R.Ph Elizabeth Jaffee, M.D. Seshu Tyagarajan, Ph.D., RAC Susan Stewart, J.D. Joseph Papa Edward J. Benz, Jr., M.D. Diem Nguyen, Ph.D., M.B.A. Chris Martell Careers Francesca Barone, M.D., Ph.D. Charu Aggarwal, M.D., MPH Philip Kantoff, M.D. Roy Herbst, M.D., Ph.D. Candel Therapeutics Announces Pricing of Initial Public Offering Henry Brem, M.D. James P. Allison, Ph.D. Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting Paul B. Manning Patrick Y. Wen, M.D. Home